Dietary precursors and cardiovascular disease: A Mendelian randomization study

被引:3
|
作者
Jing, Wangwei [1 ]
Huang, Shushi [1 ]
Xiang, Pingping [1 ]
Huang, Jiniu [1 ]
Yu, Hong [2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Hangzhou, Peoples R China
[2] Zhejiang Univ Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
dietary precursors; cardiovascular disease; Mendelian randomization (MR) analysis; choline; carnitine; HEART-FAILURE; CHOLINE; INSTRUMENTS; HEALTH; METABOLISM; INFLAMMATION; DYSFUNCTION; PLEIOTROPY; CARNITINE; IMPACT;
D O I
10.3389/fcvm.2023.1061119
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe Dietary precursor has been identified as a contributor in the development of cardiovascular disease. However, it is inconsistent if dietary precursors could affect the process of cardiovascular disease. MethodsHere we performed Mendelian randomization (MR) analysis of the data from genome-wide association study of European ancestry to evaluate the independent effects of three dietary precursors on cardiovascular disease (CVD), myocardial infarction (MI), heart failure (HF), atrial fibrillation (AF), and valvular disease (VHD). Inverse variance weighting method was used for the MR estimation. Sensitivity was determined by MR-PRESSO analysis, weighted median analysis, MR-Egger analysis, and Leave-one-out analysis. ResultsWe found that elevated choline level had a causal relationship with VHD [odds ratio (OR) = 1.087, 95% confidence interval (CI), 1.003-1.178, P = 0.041] and MI (OR = 1.250, 95% CI, 1.041-1.501, P = 0.017) by single-variable MR analysis. Furthermore, elevated carnitine level was associated with MI (OR = 5.007, 95% CI, 1.693-14.808, P = 0.004) and HF (OR = 2.176, 95% CI, 1.252-3.780, P = 0.006) risk. In addition, elevated phosphatidylcholine level can increase the risk of MI (OR = 1.197, 95% CI, 1.026-1.397, P = 0.022). ConclusionOur data show that choline increases VHD or MI risk, carnitine increases the risk of MI or HF, and phosphatidylcholine increases HF risk. These findings suggest the possibility that decrease in choline level in circulation may be able to reduce overall VHD or MI risk, reduce in carnitine level could be decrease MI and HF risks as well as decrease in phosphatidylcholine could reduce MI risk.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Mendelian randomization study on insulin resistance and risk of hypertension and cardiovascular disease
    Zhang, Fangfang
    Yu, Zhimin
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [32] Circulating levels of cytokines and risk of cardiovascular disease: a Mendelian randomization study
    Wei, Tao
    Zhu, Zhanfang
    Liu, Lin
    Liu, Bo
    Wu, Min
    Zhang, Wei
    Cui, Qianwei
    Liu, Fuqiang
    Zhang, Ronghuai
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Causality between migraine and cardiovascular disease: a bidirectional Mendelian randomization study
    Duan, Xirui
    Du, Xiaolan
    Zheng, Guangrong
    Zhou, Xinyan
    Tan, Na
    Li, Guochen
    Liu, Bin
    Zhu, Mei
    Ke, Tengfei
    Liao, Chengde
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [34] Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study
    Juan Xia
    Chunyue Guo
    Kuo Liu
    Yunyi Xie
    Han Cao
    Wenjuan Peng
    Yanyan Sun
    Xiaohui Liu
    Bingxiao Li
    Ling Zhang
    Lipids in Health and Disease, 20
  • [35] Vitiligo is associated with an increased cardiovascular disease risk: A Mendelian randomization study
    Piontkowski, A.
    Dubin, C.
    O'Hagan, R.
    Orloff, J.
    Powers, C. M.
    Gulati, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S27 - S27
  • [36] Education and cardiovascular diseases: a Mendelian randomization study
    Liu, Wei
    Lin, Quan
    Fan, Zongjing
    Cui, Jie
    Wu, Yang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [37] Genetic Risk Factors and Mendelian Randomization in Cardiovascular Disease
    Daniel I. Swerdlow
    Aroon D. Hingorani
    Steve E. Humphries
    Current Cardiology Reports, 2015, 17
  • [38] Genetic Risk Factors and Mendelian Randomization in Cardiovascular Disease
    Swerdlow, Daniel I.
    Hingorani, Aroon D.
    Humphries, Steve E.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (05)
  • [39] Causal Associations Between Circulating Adipokines and Cardiovascular Disease: A Mendelian Randomization Study
    Chen, Delong
    Zhang, Yuxuan
    Yidilisi, Abuduwufuer
    Xu, Yi
    Dong, Qichao
    Jiang, Jun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (06): : E2572 - E2580
  • [40] Mendelian randomization of chronic hepatitis B and cardiovascular disease
    Wu, Dongjie
    Xiong, Feiyang
    Ran, Qingzhi
    Liu, Jing
    Wu, Qingjuan
    Wang, Liang
    Lv, Wenliang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11